Therapeutics' Archives - Page 6 of 6 - World Asthma Foundation

February 4, 2011

Isis Spinoff Altair Therapeutics Shut Down, After Mid-Stage Asthma Study Fails – Xconomy

Isis Spinoff Altair Therapeutics Shut Down, After Mid-Stage Asthma Study Fails
Xconomy
… has shut down operations after the startup's only drug candidate failed in a mid-stage clinical trial against asthma, Xconomy has learned. …

View full post on asthma – Google News

October 5, 2010

Finck takes top medical job at NKT Therapeutics – Mass High Tech

Finck takes top medical job at NKT Therapeutics
Mass High Tech
These cells can be used to target cancer, infectious diseases, autoimmune diseases, asthma and dermatitis, company officials said. …

and more »

View full post on asthma – Google News

May 14, 2010

Pearl Therapeutics’ Bronchodilator Combination Therapeutic For COPD To Be Presented At The American Thoracic Society …

Pearl Therapeutics’ Bronchodilator Combination Therapeutic For COPD To Be Presented At The American Thoracic Society …
Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, announced four upcoming poster presentations at the Annual Meeting of the American Thoracic Society (ATS) to be held at the Ernest N. Morial Convention Center in New Orleans from May 14-19, 2010. Results from Pearl’s …